Research records indexed for Vasoactive intestinal peptide
This page carries 12 of the 8,770 records that the literature query returned for Vasoactive intestinal peptide, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 8,758 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Vasoactive intestinal peptide.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1 pmid:22289055 | 2012 | Research Support, Non-U.S. Gov't, review-article | other | Not stated | Indexed as research support, non-u.s. gov't, review-article. study model from MeSH "Animals" with no rodent species heading. subject headings: Central Nervous System; Inflammation; Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Peptide; Immunity. |
| Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine pmid:18254893 | 2008 | Comparative Study, Research Support, Non-U.S. Gov't | human trial | Not stated | Indexed as comparative study, research support, non-u.s. gov't. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Vasoactive Intestinal Peptide; Vasodilator Agents; Cross-Over Studies; Vasodilation; Migraine Disorders. |
| The significance of vasoactive intestinal peptide in immunomodulation pmid:15169929 | 2004 | Research Support, Non-U.S. Gov't, Review | other | Not stated | Indexed as research support, non-u.s. gov't, review. study model from MeSH "Animals" with no rodent species heading. subject headings: Immune System; Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Peptide; Adjuvants, Immunologic; Cytokines. |
| Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease pmid:12671893 | 2003 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Mice, Inbred Balb C". subject headings: Th1 Cells; Th2 Cells; Mice, Inbred BALB C; Colitis; Crohn Disease. |
| Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension pmid:12727925 | 2003 | Research Support, Non-U.S. Gov't, research-article | other | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Humans" with no interventional publication type. subject headings: Muscle, Smooth, Vascular; Lung; Cells, Cultured; Myocytes, Smooth Muscle; Hypertension, Pulmonary. |
| Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease pmid:11329057 | 2001 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Mice". subject headings: Th1 Cells; Th2 Cells; Mice, Inbred DBA; Arthritis, Rheumatoid; Inflammation. |
| International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide pmid:9647867 | 1998 | research-article, Review | other | Not stated | Indexed as research-article, review. study model from MeSH "Animals" with no rodent species heading. subject headings: Receptors, Vasoactive Intestinal Peptide; Receptors, Pituitary Hormone; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Terminology As Topic. |
| Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain pmid:8243312 | 1993 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Brain; Cell Line; Cytosol; Rats, Sprague-Dawley; Calcium. |
| The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide pmid:8224221 | 1993 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Rats". subject headings: Cell Line; Rats, Wistar; Receptors, Vasoactive Intestinal Peptide; DNA, Complementary; RNA, Messenger. |
| Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos pmid:8383805 | 1993 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Mice". subject headings: Central Nervous System; Secretin; Vasoactive Intestinal Peptide; GTP-Binding Proteins; Growth Substances. |
| Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts pmid:2300207 | 1990 | Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, u.s. gov't, p.h.s., research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Ganglia, Sympathetic; Neurons; Axons; Cells, Cultured; Stem Cells. |
| Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody pmid:2727702 | 1989 | Research Support, U.S. Gov't, P.H.S. | other | Not stated | Indexed as research support, u.s. gov't, p.h.s.. study model from MeSH "Humans" with no interventional publication type. subject headings: Vasoactive Intestinal Peptide; Peptide Fragments; Immunoglobulin G; Autoantibodies; Chromatography, High Pressure Liquid. |
Where this page sits
Compound page: Vasoactive intestinal peptide. Class: Endocrine and immune signalling peptides.
Retrieved 2026-10-12.
Sources
- PubChem Compound Summary for CID 16132300, Aviptadil. PubChem, National Library of Medicine (2026). pubchem:16132300
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:vip
- Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet (London, England) (1976). pmid:57443
- Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet (London, England) (1973). pmid:4123289
- International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacological reviews (1998). pmid:9647867
- Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. British journal of pharmacology (2012). pmid:22289055
- The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS letters (1993). pmid:8224221
- Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology (1993). pmid:8243312
- Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. Journal of immunology (Baltimore, Md. : 1950) (1986). pmid:2415614
- Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science (New York, N.Y.) (1989). pmid:2727702
- Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nature medicine (2001). pmid:11329057
- The significance of vasoactive intestinal peptide in immunomodulation. Pharmacological reviews (2004). pmid:15169929
- Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (1988). pmid:2845276
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.